MANF and early-onset autosomal dominant Alzheimer disease: For example, experimental models of Alzheimer’s Disease, Parkinson’s Disease and stroke have demonstrated that MANF is a neuroprotector (Li et al. 2019; Liu et al. 2018; Xu et al. 2019).